Ariane Dubost-Brama

Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried et al. · The Lancet · 2022 · 242 citations · Full text

Asthma, Uncontrolled Atopic Dermatitis, Atopic Dermatitis +4

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

Eric L. Simpson, Robert Bissonnette, Lawrence F. Eichenfield et al. · Journal of the American Academy of Dermatology · 2020 · 159 citations

Reliability, Engineering, Atopic Dermatitis +8

IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid

E. Delaporte, Ariane Dubost-Brama, R Ghohestani et al. · The Journal of Immunology · 1996 · 88 citations · Full text

Dupilumab in Adults With Moderate to Severe Atopic Dermatitis

Lisa A. Beck, Robert Bissonnette, Mette Deleuran et al. · JAMA Dermatology · 2024 · 53 citations · Full text

Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial

Eric L. Simpson, Jonathan I. Silverberg, Margitta Worm et al. · Journal of the American Academy of Dermatology · 2024 · 36 citations · Full text